Zobrazeno 1 - 10
of 31
pro vyhledávání: '"IR Harrison"'
Publikováno v:
British Journal of Clinical Pharmacology. 14:449-452
Plasma potassium and aldosterone responses to 9 days treatment with hydrochlorothiazide (100 mg/day) alone or in combination with spironolactone (100 mg/day), prescribed once daily or in doses 12 h apart, were examined in a double-blind, crossover st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4846d96d90c5a7fe944ef07d02058fc
https://doi.org/10.1111/j.1365-2125.1982.tb02007.x
https://doi.org/10.1111/j.1365-2125.1982.tb02007.x
Publikováno v:
British Journal of Clinical Pharmacology. 18:169-174
The plasma potassium responses to the aldosterone antagonists prorenoate K (10 mg/day and 40 mg/day) and spironolactone (25 mg/day and 100 mg/day) were compared following treatment for 11 days in combination with the diuretic metolazone (2.5 mg/day)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16536b724341ad4097f1742606e712e8
https://doi.org/10.1111/j.1365-2125.1984.tb02449.x
https://doi.org/10.1111/j.1365-2125.1984.tb02449.x
Publikováno v:
British Journal of Clinical Pharmacology. 13:513-518
1 The effect of single oral doses of spironolactone 25 mg, 50 mg, 100 mg, 200 mg, 400 mg, and placebo in reversing the urinary electrolyte changes induced by fludrocortisone between 2-10 h and 12-16 h after treatment was examined in healthy subjects.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7e5cddc221855901dff27c5a11382ed
https://doi.org/10.1111/j.1365-2125.1982.tb01413.x
https://doi.org/10.1111/j.1365-2125.1982.tb01413.x
Publikováno v:
British Journal of Clinical Pharmacology. 12:743-747
1 The potency of single doses of the aldosterone antagonist SC8109 relative to spironolactone in reversing the urinary electrolyte effects of fludrocortisone was examined in a double-blind, balanced, crossover study in six healthy volunteers. 2 For t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87aaa9bcb75445a497a91306f5a6cfd5
https://doi.org/10.1111/j.1365-2125.1981.tb01299.x
https://doi.org/10.1111/j.1365-2125.1981.tb01299.x
Autor:
JR Shelton, LE Ramsay, GT McInnes, RM Perkins, JM Clarke, IR Harrison, Michael J Asbury, GR Venning
Publikováno v:
British journal of clinical pharmacology. 13(3)
1 The renal antimineralocorticoid potency of single doses of thirteen compounds with properties in animals compatible with competitive aldosterone antagonism was compared to that of spironolactone in healthy men. 2 Twelve compounds showed significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0672fac91972f8689cc6addf76e2c3fd
https://pubmed.ncbi.nlm.nih.gov/6460516
https://pubmed.ncbi.nlm.nih.gov/6460516
1 After repeated single daily doses, the aldosterone antagonists prorenoate potassium and spironolactone were compared with regard to renal antimineralocorticoid activity, plasma potassium concentration and steady state plasma levels of their active
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf3f537782a7b5a02a2043ae5c4f9bb4
https://europepmc.org/articles/PMC1401979/
https://europepmc.org/articles/PMC1401979/
Autor:
IR Harrison
Publikováno v:
The Veterinary record. 77(39)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68aa383c3a8d279c296a4a68c3da153b
https://pubmed.ncbi.nlm.nih.gov/5890087
https://pubmed.ncbi.nlm.nih.gov/5890087
Publikováno v:
British Journal of Clinical Pharmacology. 9:295P-296P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3571b51183b5d97a5cdde31911dc46bb
https://doi.org/10.1111/j.1365-2125.1980.tb04854.x
https://doi.org/10.1111/j.1365-2125.1980.tb04854.x
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 1983 May; Vol. 15 (5), pp. 564-6.